| Symbol | LIMN |
|---|---|
| Name | LIMINATUS PHARMA, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 12611 HIDDENCREEK WAY, CERRITOS, CA 90703 |
| Telephone | 213-273-5453 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001971387 |
| Description |
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
Read more(99% Neutral) LIMINATUS PHARMA, INC. (LIMN) Announces Business Combination
Read more(99% Neutral) LIMINATUS PHARMA, INC. (LIMN) Announces Business Combination
Read moreNew Form SCHEDULE 13G - Liminatus Pharma, Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001104659-26-085882 <b>Size:</b> 7 KB
Read moreValetudo Therapeutics LLC 🔴 sold 4.4M shares of Liminatus Pharma, Inc. (LIMN) Transaction Date: Jun 24, 2026 | Filing ID: 080806
Read moreNew Form 3 - Liminatus Pharma, Inc. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001104659-26-080804 <b>Size:</b> 4 KB
Read moreNew Form SCHEDULE 13G/A - Liminatus Pharma, Inc. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001104659-26-080802 <b>Size:</b> 6 KB
Read more(99% Neutral) LIMINATUS PHARMA, INC. (LIMN) Announces Business Combination
Read moreLiminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
Read more(30% Negative) LIMINATUS PHARMA, INC. (LIMNW) Announces Business Combination
Read more